RS

Raju Singh

Active Director Director DIN 10837441
DIN 10837441 First appointment Nov 2024 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2024
Shareholding value Locked Premium profile

About Raju Singh

Raju Singh has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Zelinda Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10837441
Primary Designation Director
First Appointment 14 Nov 2024
Oldest Company Age 8 yrs

Current companies

Company Designation Appointment Founded Status
Director 14 Nov 2024 2018 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zelinda Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Raju Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Raju Singh

Raju Singh has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Zelinda Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Raju Singh is associated with 1 company as Director.

Raju Singh has expertise in General Business.

Raju Singh has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available